Education/CredentialsFellowship in Urologic Oncology : Memorial Hospital for Cancer and Allied DiseasesUrology Residency: University of MichiganGeneral Surgery Residency: Winnipeg General HospitalMedical Degree: University of ManitobaBachelor's Degree: University of Manitoba Board Certifications & LicensesAmerican Board of Urology (Certification Date: 19750228) Contact Information Research InterestsUrologic Oncology Clinical Interests UrologyLower Urinary Tract SymptomsMale Genitalia CancersMale Urogenital DiseasesMaple Syrup Urine DiseaseOrchitisParaphimosisPenile CancerProstate CancerProstatic HyperplasiaProstatic Intraepithelial NeoplasiaProstatitisRetractile testicleScrotal massesSeminomaSertoli Cell TumorSertoli-Leydig Cell TumorSialorrheaSpermatic CystSpermatoceleTeratocarcinomaTesticular CancerTesticular HydroceleTesticular TorsionUndescended Testicle (Cryptorchidism)Ureteral CancerUreteral DiseaseUrethral CancerUrinary Bladder DiseaseUrination DisordersUrine RetentionUrogenital CancersUrogenital SystemUrologic CancerUrologic Disease Peer Reviewed Publications Oleksowicz, Leslie; Liu, Yin; Bracken, R Bruce; Gaitonde, Krishnanath; Burke, Barbara; Succop, Paul; Levin, Linda; Dong, Zhongyun; Lu, Shan 2012. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer. The Prostate, 72 10, 1140-9Dong, Zhongyun; Liu, Yin; Scott, Kieran F; Levin, Linda; Gaitonde, Krishnanath; Bracken, R Bruce; Burke, Barbara; Zhai, Qihui Jim; Wang, Jiang; Oleksowicz, Leslie; Lu, Shan 2010. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer. Carcinogenesis, 31 11, 1948-55Sweets, Thomas; Bracken, R Bruce; Geisler, Eric J; Warnick, Ronald 2009. Intracranial treatment for solitary prostatic adenocarcinoma brain metastasis is curative. Urology, 73 3, 681.e7-9Tripp, Lloyd D; Warm, Joel S; Matthews, Gerald; Chiu, Peter Y; Bracken, R Bruce 2009. On tracking the course of cerebral oxygen saturation and pilot performance during gravity-induced loss of consciousness. Human factors, 51 6, 775-84Bruskewitz, R; Girman, C J; Fowler, J; Rigby, O F; Sullivan, M; Bracken, R B; Fusilier, H A; Kozlowski, D; Kantor, S D; Johnson, E L; Wang, D Z; Waldstreicher, J 1999. Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study. Urology, 54 4, 670-8Roehrborn, C G; Boyle, P; Bergner, D; Gray, T; Gittelman, M; Shown, T; Melman, A; Bracken, R B; deVere White, R; Taylor, A; Wang, D; Waldstreicher, J 1999. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. Urology, 54 4, 662-9Schellhammer, P F; Mardovin, W; Davis, N S; Bracken, R B; Stephenson, R A 1997. Summary of transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer (by Paul F. Schellhammer, MD, and Willet F. Whitmore, Jr, MD). 1976. Seminars in urologic oncology, 15 2, 99-104Hedden, R J; Husseinzadeh, N; Bracken, R B 1993. Bladder sparing surgery for locally advanced female urethral cancer. The Journal of urology, 150 4, 1135-7Tricoli, J V; Bracken, R B 1993. ZFY gene expression and retention in human prostate adenocarcinoma. Genes, chromosomes & cancer, 6 2, 65-72Tricoli, J V; Yao, J L; D'Souza, S A; Bracken, R B 1993. Detection of sex-region Y (SRY) transcripts in human prostate adenocarcinoma and benign prostatic hypertrophy. Genes, chromosomes & cancer, 8 1, 28-33Dodd, G D; Kaufman, P N; Bracken, R B 1991. Renal arterial duplex Doppler ultrasound in dogs with urinary obstruction. The Journal of urology, 145 3, 644-6Douglas, C; Burke, B; Kessler, D L; Cicmanec, J F; Bracken, R B 1990. Microwave: practical cost-effective method for sterilizing urinary catheters in the home. Urology, 35 3, 219-22Schwartz, B R; Gregg, R V; Kessler, D L; Bracken, R B 1989. Continuous postoperative epidural analgesia in management of postoperative surgical pain. Urology, 34 6, 349-52Lian C.;Bracken R. 06-01-1991. Urinary catheter sterilization with microwave oven International Urogynecology Journal, 2 2, 94-97Stoner E.;Bracken R.;Stein E.;Franke K.;Geller J.;Pratt C.;Imperato- McGinley J.;Vaughan E.;Orlic S.;McConnell J.;Wilson J.;Hill L.;Roy J.;Einfeldt S.;Tenover L.;Zeitner M.;Pappas F.;Gregg H. 01-01-1992. The clinical effects of a 5?-reductase inhibitor, finasteride, on benign prostatic hyperplasia Journal of Urology, 147 5, 1298-1302Shank R.A.;Barnes M.M.;Benz S.A.;Bracken R.B. 01-01-1990. Innovation in urodynamic testing: Report of the first fully computerized work station Neurourology and Urodynamics, 9 2, 155-164Bracken R.;Johnson D.;Frazier O.;Logothetis C.;Trindade A.;Samuels M. 01-01-1983. The role of surgery following chemotherapy in stage III germ cell naoplasms Journal of Urology, 129 1, 39-43Guarda L.;Jaffe N.;Bracken R.;Ayala A. 01-01-1982. Chemotherapeutic-induced histologic changes in Wilms' tumors Laboratory Investigation, 46 1, Samuels M.;Johnson D.;Bracken R. 01-01-1979. Adjuvant chemotherapy in testis cancer International Journal of Radiation Oncology Biology Physics, 5 SUPPL. 1, 48Bracken R.;Johnson D.;Miller L.;Ayala A.;Gomez J.;Rutledge F. 01-01-1977. Primary carcinoma of the female urethra Obstetrical and Gynecological Survey, 32 2, 118-119Bracken R.;Johnson D.;Miller L.;Ayala A.;Gomez J.;Rutledge F. 01-01-1976. Primary carcinoma of the female urethra Journal of Urology, 116 2, 188-192Zornoza J.;Bracken R.;Wallace S. 01-01-1976. Radiologic features of adrenal metastases Urology, 8 3, 295-299Goldstein H.;Medellin H.;Beydoun M.;Wallace S.;Ben-Menachem Y.;Bracken R.;Johnson D. 01-01-1975. Transcatheter embolization of renal cell carcinoma AMER.J.ROENTGENOL., 123 3, 557-562
Clinical Interests UrologyLower Urinary Tract SymptomsMale Genitalia CancersMale Urogenital DiseasesMaple Syrup Urine DiseaseOrchitisParaphimosisPenile CancerProstate CancerProstatic HyperplasiaProstatic Intraepithelial NeoplasiaProstatitisRetractile testicleScrotal massesSeminomaSertoli Cell TumorSertoli-Leydig Cell TumorSialorrheaSpermatic CystSpermatoceleTeratocarcinomaTesticular CancerTesticular HydroceleTesticular TorsionUndescended Testicle (Cryptorchidism)Ureteral CancerUreteral DiseaseUrethral CancerUrinary Bladder DiseaseUrination DisordersUrine RetentionUrogenital CancersUrogenital SystemUrologic CancerUrologic Disease
Peer Reviewed Publications Oleksowicz, Leslie; Liu, Yin; Bracken, R Bruce; Gaitonde, Krishnanath; Burke, Barbara; Succop, Paul; Levin, Linda; Dong, Zhongyun; Lu, Shan 2012. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer. The Prostate, 72 10, 1140-9Dong, Zhongyun; Liu, Yin; Scott, Kieran F; Levin, Linda; Gaitonde, Krishnanath; Bracken, R Bruce; Burke, Barbara; Zhai, Qihui Jim; Wang, Jiang; Oleksowicz, Leslie; Lu, Shan 2010. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer. Carcinogenesis, 31 11, 1948-55Sweets, Thomas; Bracken, R Bruce; Geisler, Eric J; Warnick, Ronald 2009. Intracranial treatment for solitary prostatic adenocarcinoma brain metastasis is curative. Urology, 73 3, 681.e7-9Tripp, Lloyd D; Warm, Joel S; Matthews, Gerald; Chiu, Peter Y; Bracken, R Bruce 2009. On tracking the course of cerebral oxygen saturation and pilot performance during gravity-induced loss of consciousness. Human factors, 51 6, 775-84Bruskewitz, R; Girman, C J; Fowler, J; Rigby, O F; Sullivan, M; Bracken, R B; Fusilier, H A; Kozlowski, D; Kantor, S D; Johnson, E L; Wang, D Z; Waldstreicher, J 1999. Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study. Urology, 54 4, 670-8Roehrborn, C G; Boyle, P; Bergner, D; Gray, T; Gittelman, M; Shown, T; Melman, A; Bracken, R B; deVere White, R; Taylor, A; Wang, D; Waldstreicher, J 1999. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. Urology, 54 4, 662-9Schellhammer, P F; Mardovin, W; Davis, N S; Bracken, R B; Stephenson, R A 1997. Summary of transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer (by Paul F. Schellhammer, MD, and Willet F. Whitmore, Jr, MD). 1976. Seminars in urologic oncology, 15 2, 99-104Hedden, R J; Husseinzadeh, N; Bracken, R B 1993. Bladder sparing surgery for locally advanced female urethral cancer. The Journal of urology, 150 4, 1135-7Tricoli, J V; Bracken, R B 1993. ZFY gene expression and retention in human prostate adenocarcinoma. Genes, chromosomes & cancer, 6 2, 65-72Tricoli, J V; Yao, J L; D'Souza, S A; Bracken, R B 1993. Detection of sex-region Y (SRY) transcripts in human prostate adenocarcinoma and benign prostatic hypertrophy. Genes, chromosomes & cancer, 8 1, 28-33Dodd, G D; Kaufman, P N; Bracken, R B 1991. Renal arterial duplex Doppler ultrasound in dogs with urinary obstruction. The Journal of urology, 145 3, 644-6Douglas, C; Burke, B; Kessler, D L; Cicmanec, J F; Bracken, R B 1990. Microwave: practical cost-effective method for sterilizing urinary catheters in the home. Urology, 35 3, 219-22Schwartz, B R; Gregg, R V; Kessler, D L; Bracken, R B 1989. Continuous postoperative epidural analgesia in management of postoperative surgical pain. Urology, 34 6, 349-52Lian C.;Bracken R. 06-01-1991. Urinary catheter sterilization with microwave oven International Urogynecology Journal, 2 2, 94-97Stoner E.;Bracken R.;Stein E.;Franke K.;Geller J.;Pratt C.;Imperato- McGinley J.;Vaughan E.;Orlic S.;McConnell J.;Wilson J.;Hill L.;Roy J.;Einfeldt S.;Tenover L.;Zeitner M.;Pappas F.;Gregg H. 01-01-1992. The clinical effects of a 5?-reductase inhibitor, finasteride, on benign prostatic hyperplasia Journal of Urology, 147 5, 1298-1302Shank R.A.;Barnes M.M.;Benz S.A.;Bracken R.B. 01-01-1990. Innovation in urodynamic testing: Report of the first fully computerized work station Neurourology and Urodynamics, 9 2, 155-164Bracken R.;Johnson D.;Frazier O.;Logothetis C.;Trindade A.;Samuels M. 01-01-1983. The role of surgery following chemotherapy in stage III germ cell naoplasms Journal of Urology, 129 1, 39-43Guarda L.;Jaffe N.;Bracken R.;Ayala A. 01-01-1982. Chemotherapeutic-induced histologic changes in Wilms' tumors Laboratory Investigation, 46 1, Samuels M.;Johnson D.;Bracken R. 01-01-1979. Adjuvant chemotherapy in testis cancer International Journal of Radiation Oncology Biology Physics, 5 SUPPL. 1, 48Bracken R.;Johnson D.;Miller L.;Ayala A.;Gomez J.;Rutledge F. 01-01-1977. Primary carcinoma of the female urethra Obstetrical and Gynecological Survey, 32 2, 118-119Bracken R.;Johnson D.;Miller L.;Ayala A.;Gomez J.;Rutledge F. 01-01-1976. Primary carcinoma of the female urethra Journal of Urology, 116 2, 188-192Zornoza J.;Bracken R.;Wallace S. 01-01-1976. Radiologic features of adrenal metastases Urology, 8 3, 295-299Goldstein H.;Medellin H.;Beydoun M.;Wallace S.;Ben-Menachem Y.;Bracken R.;Johnson D. 01-01-1975. Transcatheter embolization of renal cell carcinoma AMER.J.ROENTGENOL., 123 3, 557-562
Oleksowicz, Leslie; Liu, Yin; Bracken, R Bruce; Gaitonde, Krishnanath; Burke, Barbara; Succop, Paul; Levin, Linda; Dong, Zhongyun; Lu, Shan 2012. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer. The Prostate, 72 10, 1140-9Dong, Zhongyun; Liu, Yin; Scott, Kieran F; Levin, Linda; Gaitonde, Krishnanath; Bracken, R Bruce; Burke, Barbara; Zhai, Qihui Jim; Wang, Jiang; Oleksowicz, Leslie; Lu, Shan 2010. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer. Carcinogenesis, 31 11, 1948-55Sweets, Thomas; Bracken, R Bruce; Geisler, Eric J; Warnick, Ronald 2009. Intracranial treatment for solitary prostatic adenocarcinoma brain metastasis is curative. Urology, 73 3, 681.e7-9Tripp, Lloyd D; Warm, Joel S; Matthews, Gerald; Chiu, Peter Y; Bracken, R Bruce 2009. On tracking the course of cerebral oxygen saturation and pilot performance during gravity-induced loss of consciousness. Human factors, 51 6, 775-84Bruskewitz, R; Girman, C J; Fowler, J; Rigby, O F; Sullivan, M; Bracken, R B; Fusilier, H A; Kozlowski, D; Kantor, S D; Johnson, E L; Wang, D Z; Waldstreicher, J 1999. Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study. Urology, 54 4, 670-8Roehrborn, C G; Boyle, P; Bergner, D; Gray, T; Gittelman, M; Shown, T; Melman, A; Bracken, R B; deVere White, R; Taylor, A; Wang, D; Waldstreicher, J 1999. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. Urology, 54 4, 662-9Schellhammer, P F; Mardovin, W; Davis, N S; Bracken, R B; Stephenson, R A 1997. Summary of transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer (by Paul F. Schellhammer, MD, and Willet F. Whitmore, Jr, MD). 1976. Seminars in urologic oncology, 15 2, 99-104Hedden, R J; Husseinzadeh, N; Bracken, R B 1993. Bladder sparing surgery for locally advanced female urethral cancer. The Journal of urology, 150 4, 1135-7Tricoli, J V; Bracken, R B 1993. ZFY gene expression and retention in human prostate adenocarcinoma. Genes, chromosomes & cancer, 6 2, 65-72Tricoli, J V; Yao, J L; D'Souza, S A; Bracken, R B 1993. Detection of sex-region Y (SRY) transcripts in human prostate adenocarcinoma and benign prostatic hypertrophy. Genes, chromosomes & cancer, 8 1, 28-33Dodd, G D; Kaufman, P N; Bracken, R B 1991. Renal arterial duplex Doppler ultrasound in dogs with urinary obstruction. The Journal of urology, 145 3, 644-6Douglas, C; Burke, B; Kessler, D L; Cicmanec, J F; Bracken, R B 1990. Microwave: practical cost-effective method for sterilizing urinary catheters in the home. Urology, 35 3, 219-22Schwartz, B R; Gregg, R V; Kessler, D L; Bracken, R B 1989. Continuous postoperative epidural analgesia in management of postoperative surgical pain. Urology, 34 6, 349-52Lian C.;Bracken R. 06-01-1991. Urinary catheter sterilization with microwave oven International Urogynecology Journal, 2 2, 94-97Stoner E.;Bracken R.;Stein E.;Franke K.;Geller J.;Pratt C.;Imperato- McGinley J.;Vaughan E.;Orlic S.;McConnell J.;Wilson J.;Hill L.;Roy J.;Einfeldt S.;Tenover L.;Zeitner M.;Pappas F.;Gregg H. 01-01-1992. The clinical effects of a 5?-reductase inhibitor, finasteride, on benign prostatic hyperplasia Journal of Urology, 147 5, 1298-1302Shank R.A.;Barnes M.M.;Benz S.A.;Bracken R.B. 01-01-1990. Innovation in urodynamic testing: Report of the first fully computerized work station Neurourology and Urodynamics, 9 2, 155-164Bracken R.;Johnson D.;Frazier O.;Logothetis C.;Trindade A.;Samuels M. 01-01-1983. The role of surgery following chemotherapy in stage III germ cell naoplasms Journal of Urology, 129 1, 39-43Guarda L.;Jaffe N.;Bracken R.;Ayala A. 01-01-1982. Chemotherapeutic-induced histologic changes in Wilms' tumors Laboratory Investigation, 46 1, Samuels M.;Johnson D.;Bracken R. 01-01-1979. Adjuvant chemotherapy in testis cancer International Journal of Radiation Oncology Biology Physics, 5 SUPPL. 1, 48Bracken R.;Johnson D.;Miller L.;Ayala A.;Gomez J.;Rutledge F. 01-01-1977. Primary carcinoma of the female urethra Obstetrical and Gynecological Survey, 32 2, 118-119Bracken R.;Johnson D.;Miller L.;Ayala A.;Gomez J.;Rutledge F. 01-01-1976. Primary carcinoma of the female urethra Journal of Urology, 116 2, 188-192Zornoza J.;Bracken R.;Wallace S. 01-01-1976. Radiologic features of adrenal metastases Urology, 8 3, 295-299Goldstein H.;Medellin H.;Beydoun M.;Wallace S.;Ben-Menachem Y.;Bracken R.;Johnson D. 01-01-1975. Transcatheter embolization of renal cell carcinoma AMER.J.ROENTGENOL., 123 3, 557-562